Laboratory Corporation of America Holdings (LH) Stock Forecast
Show ratings and price targets of :
Alert
Its only available to paid users.
USD 267.19
(+6.94%)
Based on the Laboratory Corporation of America Holdings stock forecast from 10 analysts, the average analyst target price for Laboratory Corporation of America Holdings is USD 267.19 over the next 12 months. Laboratory Corporation of America Holdings’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Laboratory Corporation of America Holdings is Slightly Bearish, which is based on 5 positive signals and 9 negative signals. At the last closing, Laboratory Corporation of America Holdings’s stock price was USD 249.85. Laboratory Corporation of America Holdings’s stock price has changed by +1.36% over the past week, +2.26% over the past month and +14.00% over the last year.
No recent analyst target price found for Laboratory Corporation of America Holdings
No recent average analyst rating found for Laboratory Corporation of America Holdings
Company Overview Laboratory Corporation of America Holdings
Labcorp Holdings Inc. provides laboratory services. It operates through two segments, Diagnostics Laboratories and Biopharma Laboratory Services. The company offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid, PAP, hemoglobin A1C and vitamin D, prostate-specific antigens, sexually transmitted diseases, hepatitis C, microbiology cultures and procedures, and alcohol and other substance-abuse tests. It also provides specialty testing services comprising gene-based and esoteric testing; advanced tests target specific diseases; services related to anatomic pathology/oncology, cardiovascular disease, coagulation, diagnostic genetics, endocrinology, infectious disease, women's health, pharmacogenetics, parentage and donor testing, occupational testing services, medical drug monitoring services, chronic disease programs, and kidney stone prevention tests; and health and wellness services to employers and managed care organizations (MCOs). In addition, the company offers online and mobile applications that enable patients to check test results; online applications for providers, MCOs, and accountable care organizations; specimen collection services; and drug development, medical device, and companion diagnostic development solutions, as well as support for crop protection and chemical testing. It serves pharmaceutical, biotechnology, medical device, and diagnostics companies; and MCOs, employer plans, other health insurance providers, governmental agencies, physicians and other healthcare providers, hospitals and health systems, employers, patients and consumers, contract research organizations, crop protection and chemical companies, academic institutions, independent clinical laboratories, and retailers. The company was founded in 1995 is headquartered in Burlington, North Carolina. Read Less
Labcorp Holdings Inc. provides laboratory services. It operates through two segments, Diagnostics Laboratories and Biopharma Laboratory Services. The company offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid, PAP, hemoglobin A1C and vi...Read More
Frequently Asked Questions About Laboratory Corporation of America Holdings (LH) Stock
Based on ratings from 10 analysts Laboratory Corporation of America Holdings's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Slightly Bearish. The stock has 13 buy, sell and 7 hold ratings.
LH stock's dividend yield is 1.15%.
Our analysis grades LH stock's dividend yield at F. This means that LH stock's dividend yield is above 50% of the stocks in the Diagnostics & Research sector in the NYE exchange.
Based on this LH may be a average dividend stock for its sector.
Based on targets from 10 analysts, the average taret price for LH is USD 267.19 over the next 12 months. The maximum analyst target price is USD 293 while the minimum anlayst target price is USD 235.
LH stock's Price/Earning ratio is 27.86.
Our analysis grades LH stock's Price / Earning ratio at C. This means that LH stock's Price/Earning ratio is above 25% of the stocks in the Diagnostics & Research sector in the NYE exchange.
Based on this LH may be undervalued for its sector.
The last closing price of LH's stock was USD 249.85.
The most recent market capitalization for LH is USD 20.54B.
Based on targets from 10 analysts, the average taret price for LH is projected at USD 267.19 over the next 12 months.
This means that LH's stock price may go up by +6.94% over the next 12 months.
We can't find any ETFs which contains Laboratory Corporation of America Holdings's stock.
As per our most recent records Laboratory Corporation of America Holdings has 67,000 Employees.
Laboratory Corporation of America Holdings's registered address is 358 South Main Street, Burlington, NC, United States, 27215.
You can get more information about it from Laboratory Corporation of America Holdings's website at https://www.labcorp.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Underpriced compared to book value
The stock is trading low compared to its peers on a price to book value basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.
Positive cash flow
The company had positive total cash flow in the most recent four quarters.
Positive free cash flow
The company had positive total free cash flow in the most recent four quarters.
Underpriced compared to earnings
The stock is trading low compared to its peers on a price to earning basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.
High Gross Profit to Asset Ratio
This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.
What not to like
Poor capital utilization
The company management has delivered below median return on invested capital in the most recent 4 quarters compared to its peers.
Poor return on assets
The company management has delivered below median return on assets in the most recent 4 quarters compared to its peers.
High volatility
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
Overpriced on cashflow basis
The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Poor return on equity
The company management has delivered below median return on equity in the most recent 4 quarters compared to its peers.
Low Revenue Growth
This stock has shown below median revenue growth in the previous 5 years compared to its sector
Low Earnings Growth
This stock has shown below median earnings growth in the previous 5 years compared to its sector
Highly leveraged
The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.
Overpriced on free cash flow basis
The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Frequently Asked Questions About Laboratory Corporation of America Holdings (LH) Stock
Based on ratings from 10 analysts Laboratory Corporation of America Holdings's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Slightly Bearish. The stock has 13 buy, sell and 7 hold ratings.
LH stock's dividend yield is 1.15%.
Our analysis grades LH stock's dividend yield at F. This means that LH stock's dividend yield is above 50% of the stocks in the Diagnostics & Research sector in the NYE exchange.
Based on this LH may be a average dividend stock for its sector.
Based on targets from 10 analysts, the average taret price for LH is USD 267.19 over the next 12 months. The maximum analyst target price is USD 293 while the minimum anlayst target price is USD 235.
LH stock's Price/Earning ratio is 27.86.
Our analysis grades LH stock's Price / Earning ratio at C. This means that LH stock's Price/Earning ratio is above 25% of the stocks in the Diagnostics & Research sector in the NYE exchange.
Based on this LH may be undervalued for its sector.
The last closing price of LH's stock was USD 249.85.
The most recent market capitalization for LH is USD 20.54B.
Based on targets from 10 analysts, the average taret price for LH is projected at USD 267.19 over the next 12 months.
This means that LH's stock price may go up by +6.94% over the next 12 months.
We can't find any ETFs which contains Laboratory Corporation of America Holdings's stock.
As per our most recent records Laboratory Corporation of America Holdings has 67,000 Employees.
Laboratory Corporation of America Holdings's registered address is 358 South Main Street, Burlington, NC, United States, 27215.
You can get more information about it from Laboratory Corporation of America Holdings's website at https://www.labcorp.com.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for LH !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
